CTI BIOPHARMA CORP

CUSIP: 12648L601 Class: Common Stock

SILVERARC CAPITAL MANAGEMENT, LLC's Holding History (CIK: 0001816307)

Note: Option positions (PUT/CALL) are excluded.

Q4 2022
Shares 254,361 Value ($000) $1,529 Avg Close — Range —
Q3 2022
Shares 983,516 Value ($000) $5,724 Avg Close — Range —
Q2 2022
Shares 1,380,111 Value ($000) $8,239 Avg Close — Range —
Q1 2022
Shares 2,250,000 Value ($000) $10,508 Avg Close — Range —
Q4 2021
Shares 1,483,829 Value ($000) $3,680 Avg Close — Range —